Plaquenil and mastocytosis

We report the efficacy of hydroxychloroquine in four patients with mast cell disease. This review focuses on the current state of drug therapy in SM and MCAS and describes perspectives of promising new approaches for drug treatment

2024-03-28
    Dulcolax and kidney function
  1. Author disclosure: Nothing to disclose
  2. The disease follows a benign course in most
  3. trouble with breathing, speaking, or swallowing
  4. It will take 1 to 2 months to begin working
  5. loss of hearing
  6. These dosages are based on a child’s weight in kg